Olga Uspenskaya-Cadoz
Company: VectorY Therapeutics
Job title: Chief Medical Officer
Seminars:
Chair’s Closing Remarks 4:20 pm
day: Conference Day Two PM
Chair’s Opening Remarks 8:25 am
day: Conference Day Two
Panel Discussion: Given Recent Failures, How Can we Tailor ALS Clinical Trials to Successfully Meet Regulatory Expectations 1:30 pm
Outlining the approval path for sporadic and familial ALS: is it the same for different modalities? What is the regulatory bar for approving this? Harnessing innovative trial design Cross comparing diverging requirements for different regulatory agencies including the FDA, EMA and more Establishing clear, patient-relevant endpoints and leveraging biomarkers to demonstrate efficacy Critically identifying stumbling…Read more
day: Conference Day One Track B PM
Chair’s Opening Remarks 7:55 am
day: Conference Day One
Chair’s Closing Remarks 5:40 pm
day: Conference Day One PM